(S)-4-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)butanoic acid, 95.0%, 25g

2'-Methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-carboxylic acid, 98%, 100mg

7-Iodo-2H-benzo[b][1,4]oxazin-3(4H)-one, 95.0%, 1g

Zotarolimus, 98.59%, 1mg

Benzyl 2-((tert-butoxycarbonyl)amino)-7-azaspiro[3.5]Nonane-7-carboxylate, 98%, 250mg

1H-Imidazo[4,5-c]pyridine-2(3H)-thione, 95.0%, 1g

Graphene Nanoplatelets Aggregates (sub-micron particles, surface area 300m2/g)25g

Methyl 6-amino-4-methylpyridine-3-carboxylate, 95+%, 10g

Cucurbituril, 1g

1-(3-PYRIDYL)ETHYLAMINE 2HCL, 97.0%, 1g

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole, 95.0%, 25g

3,6-Di(pyridin-4-yl)-9H-carbazole, 98%, 100mg

Ethyl 3-(N-ethyl-3-methylbenzamido)propanoate, 97%, 250mg